The choice of the cell substrate for human virus vaccine production
Hayflick, L.
Laboratory Practice 19(1): 58-62
1970
ISSN/ISBN: 0023-6853 PMID: 4984599 Document Number: 20804
Document emailed within 1 workday
Related Documents
Rau, C.; Voiculescu, C.; Palade, V. 1976: The significance of positive controls in testing the oncogenic potential of cell material for virus vaccine production Developments in Biological Standardization 37: 241-244Biggs, P.M. 1970: Production of pathogen free avian cell substrate for production of vaccines Laboratory Practice 19(1): 45-49
Larsson, B.; Litwin, J. 1980: Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production Developments in Biological Standardization 46: 241-247
Arai, Y.T.; Montalban, C.S. 1993: Comparative studies on chick embryo cell rabies vaccine and human diploid cell vaccine: pre-exposure use and purity of the vaccines Southeast Asian Journal of Tropical Medicine and Public Health 24(4): 747-750
Frankel, F.R.; Hegde, S.; Lieberman, J.; Paterson, Y. 1995: Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector Journal of Immunology 155(10): 4775-4782
Aida, Y.; Amanuma, H.; Okada, K. 1994: Identification of tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma cells and expression of its human homologue in human T-cell lymphotrophic virus I-infected cell lines Leukemia 8(Suppl): S231-S234
Majer, M. 1970: Cell-containing substrates and vaccine production Schweizerische Medizinische Wochenschrift 100(48): 2086-2089
Rozovskaia, T.A.; Belogurov, A.A.; Lukin, M.A.; Chernov, D.N.; Kukhanova, M.K.; Bibilashvili, R.S. 1993: Reverse transcriptase of the human immunodeficiency virus: isolation and substrate specificity Molekuliarnaia Biologiia 27(3): 618-630
Kretzschmar, C. 1983: Eradicability of infectious bovine rhinotracheitis (IBR)/infectious pustular vulvovaginitis (IPV) virus infection. 2. Studies of the virus latency of Riems IBR/IPV vaccine (live viral vaccine) virus strain and field virus following infection of immunized animals Archiv für Experimentelle Veterinarmedizin 37(6): 829-835
Davydkin, V.I.; Davydkin, I.I.; Aleshkin, V.A.; Gavrin, A.G.; Vorob'ev, A.A.; Afanas'ev, S.S. 2001: Method of production of the dried highly dispersed vaccine of Newcastle disease virus Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 45-49
Vasil'eva, N.N.; Chernos, V.I.; Andzhaparidze, O.G. 1972: Comparative study of the genetic stability of vaccinia virus strains used in vaccine production in the USSR Voprosy Virusologii 17(5): 524-528
Altanerová, V. 1972: Virus production induced by various chemical carcinogens in a virogenic hamster cell line transformed by Rous sarcoma virus Journal of the National Cancer Institute 49(5): 1375-1380
Bognár, K. 1974: Experiences in the production control and field application of vaccine and serum against bovine virus diarrhea in Hungary Developments in Biological Standardization 26: 19-24
Serokowa, D. 1979: Advances in the production and control of human rabies vaccine Przeglad Epidemiologiczny 33(1): 42-54
Khvatov, V.B.; Petrenko, O.A. 1975: Production of a specific substrate-human plasminogen--for the quantitative determination of plasminogen activator in the blood plasma in sudden death Problemy Gematologii i Perelivaniia Krovi 20(6): 57-60
Mori, N.; Prager, D. 1996: High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax Cancer Research 56(4): 779-782
Pampuro, S.E.; Rabinovich, R.D.; Martinez Peralta, L.; Gallo, D.; Hanson, C.; Libonatti, O. 1993: Presence of human T-cell lymphotropic virus types i and Ii and coinfection with human immunodeficiency virus in different groups at risk in Argentina Journal of Acquired Immune Deficiency Syndromes 6(7): 851-852
Pampuro, S.E.; Rabinovich, R.D.; Martinez Peralta, L.; Gallo, D.; Hanson, C.; Libonatti, O. 1993: Presence of human T-cell lymphotropic virus types i and Ii and coinfection with human immunodeficiency virus in different groups at risk in Argentina Journal of Acquired Immune Deficiency Syndromes 6(7): 851-852
Ferguson, J.D.; Galligan, D.T.; Cortese, V. 1997: Milk production and reproductive performance in dairy cows given bovine respiratory syncytial virus vaccine prior to parturition Journal of the American Veterinary Medical Association 210(12): 1779-1783
Brown, A.L.; Merry, D.L.; Beckenhauer, W.H. 1973: Modified live-virus rabies vaccine produced from flury high egg-passage virus grown on an established canine-kidney cell line: three-year duration-of-immunity study in dogs American Journal of Veterinary Research 34(11): 1427-1432